Delivery Order SPE2DB20D3101-SPE2DB22FQST2
Award Date 8/24/22
Potential Completion Date 8/25/22
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,786.67 under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,541.04, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 15, 2021. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a larger...
- This federal contract award, valued at $1,177.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Spiriva Respimat 1.25 MCG INH 4GM, a pharmaceutical product used for respiratory conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 19, 2023. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalers to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $7,112.62. The contract has a firm fixed price and is set to be completed by April 25, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,313.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, a pharmaceutical product used to treat respiratory conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a total ceiling value of $2,763.66. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as a primary...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $2,825.52 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC...
- This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, valued at $1,102.08. The award was made by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The contract has a ceiling value of $1,102.08 and is a delivery order under an Indefinite Delivery Contract (IDC) held...
- This federal contract award, valued at $1,801.54, was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,559,628,441 units of Spiriva Respimat 2.5 MCG inhalation medication in a 4 GM size. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC...
- This federal contract award is for the delivery of Spiriva 18 MCG CP-HANDIHALER 30S medication to the Defense Logistics Agency (DLA). The contract, valued at $35,573.19, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FQST2Delivery Order
This federal contract award is for the delivery of the pharmaceutical product Spiriva Respimat 1.25 MCG INH 4GM to the Defense Logistics Agency (DLA). The contract, valued at $1,758.81, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.
Generated 2/27/25, 12:37 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/24/22 |